Logo image of HZO

MARINEMAX INC (HZO) Stock Fundamental Analysis

NYSE:HZO - New York Stock Exchange, Inc. - US5679081084 - Common Stock - Currency: USD

26.78  -1.06 (-3.81%)

After market: 26.78 0 (0%)

Fundamental Rating

4

HZO gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 120 industry peers in the Specialty Retail industry. HZO has a medium profitability rating, but doesn't score so well on its financial health evaluation. HZO has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

HZO had positive earnings in the past year.
In the past year HZO has reported a negative cash flow from operations.
In the past 5 years HZO has always been profitable.
The reported operating cash flow has been mixed in the past 5 years: HZO reported negative operating cash flow in multiple years.
HZO Yearly Net Income VS EBIT VS OCF VS FCFHZO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

HZO's Return On Assets of 2.10% is in line compared to the rest of the industry. HZO outperforms 55.56% of its industry peers.
Looking at the Return On Equity, with a value of 5.56%, HZO is in the better half of the industry, outperforming 60.68% of the companies in the same industry.
With a Return On Invested Capital value of 4.61%, HZO perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for HZO is below the industry average of 12.30%.
The last Return On Invested Capital (4.61%) for HZO is well below the 3 year average (9.69%), which needs to be investigated, but indicates that HZO had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.1%
ROE 5.56%
ROIC 4.61%
ROA(3y)6.87%
ROA(5y)9.12%
ROE(3y)13.71%
ROE(5y)16.71%
ROIC(3y)9.69%
ROIC(5y)12.16%
HZO Yearly ROA, ROE, ROICHZO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

Looking at the Profit Margin, with a value of 2.33%, HZO is in the better half of the industry, outperforming 60.68% of the companies in the same industry.
HZO's Profit Margin has declined in the last couple of years.
HZO has a better Operating Margin (6.25%) than 71.79% of its industry peers.
HZO's Operating Margin has improved in the last couple of years.
HZO's Gross Margin of 33.53% is in line compared to the rest of the industry. HZO outperforms 42.73% of its industry peers.
In the last couple of years the Gross Margin of HZO has grown nicely.
Industry RankSector Rank
OM 6.25%
PM (TTM) 2.33%
GM 33.53%
OM growth 3Y-19.61%
OM growth 5Y1.53%
PM growth 3Y-40.71%
PM growth 5Y-11.66%
GM growth 3Y1.03%
GM growth 5Y4.78%
HZO Yearly Profit, Operating, Gross MarginsHZO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HZO is still creating some value.
The number of shares outstanding for HZO has been increased compared to 1 year ago.
HZO has more shares outstanding than it did 5 years ago.
The debt/assets ratio for HZO is higher compared to a year ago.
HZO Yearly Shares OutstandingHZO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
HZO Yearly Total Debt VS Total AssetsHZO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 1.83 indicates that HZO is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.83, HZO perfoms like the industry average, outperforming 40.17% of the companies in the same industry.
HZO has a Debt/Equity ratio of 1.15. This is a high value indicating a heavy dependency on external financing.
HZO has a Debt to Equity ratio (1.15) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF N/A
Altman-Z 1.83
ROIC/WACC0.49
WACC9.47%
HZO Yearly LT Debt VS Equity VS FCFHZO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

2.3 Liquidity

HZO has a Current Ratio of 1.19. This is a normal value and indicates that HZO is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of HZO (1.19) is worse than 64.10% of its industry peers.
A Quick Ratio of 0.24 indicates that HZO may have some problems paying its short term obligations.
HZO's Quick ratio of 0.24 is on the low side compared to the rest of the industry. HZO is outperformed by 81.20% of its industry peers.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 0.24
HZO Yearly Current Assets VS Current LiabilitesHZO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

HZO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -49.76%.
HZO shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.01% yearly.
The Revenue has decreased by -1.73% in the past year.
HZO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.46% yearly.
EPS 1Y (TTM)-49.76%
EPS 3Y-32.09%
EPS 5Y5.01%
EPS Q2Q%-10.53%
Revenue 1Y (TTM)-1.73%
Revenue growth 3Y5.62%
Revenue growth 5Y14.46%
Sales Q2Q%-11.15%

3.2 Future

HZO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.77% yearly.
HZO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.95% yearly.
EPS Next Y12.52%
EPS Next 2Y25.36%
EPS Next 3Y23.77%
EPS Next 5YN/A
Revenue Next Year-1.25%
Revenue Next 2Y2.2%
Revenue Next 3Y1.95%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HZO Yearly Revenue VS EstimatesHZO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
HZO Yearly EPS VS EstimatesHZO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

6

4. Valuation

4.1 Price/Earnings Ratio

HZO is valuated correctly with a Price/Earnings ratio of 12.75.
HZO's Price/Earnings ratio is a bit cheaper when compared to the industry. HZO is cheaper than 79.49% of the companies in the same industry.
HZO is valuated cheaply when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 8.04 indicates a reasonable valuation of HZO.
Based on the Price/Forward Earnings ratio, HZO is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
HZO's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.68.
Industry RankSector Rank
PE 12.75
Fwd PE 8.04
HZO Price Earnings VS Forward Price EarningsHZO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HZO is valued cheaply inside the industry as 91.45% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.37
HZO Per share dataHZO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
HZO's earnings are expected to grow with 23.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.02
PEG (5Y)2.54
EPS Next 2Y25.36%
EPS Next 3Y23.77%

0

5. Dividend

5.1 Amount

HZO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MARINEMAX INC

NYSE:HZO (2/21/2025, 8:26:26 PM)

After market: 26.78 0 (0%)

26.78

-1.06 (-3.81%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)01-23 2025-01-23/bmo
Earnings (Next)04-23 2025-04-23/bmo
Inst Owners88.02%
Inst Owner Change-94.44%
Ins Owners2.85%
Ins Owner Change13.84%
Market Cap608.17M
Analysts81.54
Price Target39.34 (46.9%)
Short Float %9.68%
Short Ratio7.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)84.26%
Min EPS beat(2)-20.95%
Max EPS beat(2)189.48%
EPS beat(4)2
Avg EPS beat(4)25.56%
Min EPS beat(4)-72.88%
Max EPS beat(4)189.48%
EPS beat(8)3
Avg EPS beat(8)1.56%
EPS beat(12)6
Avg EPS beat(12)5.43%
EPS beat(16)10
Avg EPS beat(16)17.53%
Revenue beat(2)0
Avg Revenue beat(2)-4.42%
Min Revenue beat(2)-4.44%
Max Revenue beat(2)-4.39%
Revenue beat(4)1
Avg Revenue beat(4)-1.92%
Min Revenue beat(4)-4.44%
Max Revenue beat(4)3.36%
Revenue beat(8)4
Avg Revenue beat(8)0.4%
Revenue beat(12)6
Avg Revenue beat(12)0.38%
Revenue beat(16)9
Avg Revenue beat(16)1.26%
PT rev (1m)-3.27%
PT rev (3m)-3.27%
EPS NQ rev (1m)-25.95%
EPS NQ rev (3m)-59.5%
EPS NY rev (1m)-1.65%
EPS NY rev (3m)-6.33%
Revenue NQ rev (1m)0.54%
Revenue NQ rev (3m)-5.56%
Revenue NY rev (1m)-0.49%
Revenue NY rev (3m)-1.25%
Valuation
Industry RankSector Rank
PE 12.75
Fwd PE 8.04
P/S 0.26
P/FCF N/A
P/OCF N/A
P/B 0.61
P/tB 1.66
EV/EBITDA 4.37
EPS(TTM)2.1
EY7.84%
EPS(NY)3.33
Fwd EY12.44%
FCF(TTM)-6.52
FCFYN/A
OCF(TTM)-3.64
OCFYN/A
SpS104.46
BVpS43.75
TBVpS16.16
PEG (NY)1.02
PEG (5Y)2.54
Profitability
Industry RankSector Rank
ROA 2.1%
ROE 5.56%
ROCE 9.61%
ROIC 4.61%
ROICexc 4.92%
ROICexgc 6.88%
OM 6.25%
PM (TTM) 2.33%
GM 33.53%
FCFM N/A
ROA(3y)6.87%
ROA(5y)9.12%
ROE(3y)13.71%
ROE(5y)16.71%
ROIC(3y)9.69%
ROIC(5y)12.16%
ROICexc(3y)11.72%
ROICexc(5y)15.7%
ROICexgc(3y)16.73%
ROICexgc(5y)22.44%
ROCE(3y)16.44%
ROCE(5y)19.71%
ROICexcg growth 3Y-46.03%
ROICexcg growth 5Y-2.42%
ROICexc growth 3Y-44.7%
ROICexc growth 5Y-7.52%
OM growth 3Y-19.61%
OM growth 5Y1.53%
PM growth 3Y-40.71%
PM growth 5Y-11.66%
GM growth 3Y1.03%
GM growth 5Y4.78%
F-Score2
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF N/A
Debt/EBITDA 5.91
Cap/Depr 144.87%
Cap/Sales 2.76%
Interest Coverage 1.85
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 0.24
Altman-Z 1.83
F-Score2
WACC9.47%
ROIC/WACC0.49
Cap/Depr(3y)198.93%
Cap/Depr(5y)172.82%
Cap/Sales(3y)2.58%
Cap/Sales(5y)1.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.76%
EPS 3Y-32.09%
EPS 5Y5.01%
EPS Q2Q%-10.53%
EPS Next Y12.52%
EPS Next 2Y25.36%
EPS Next 3Y23.77%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.73%
Revenue growth 3Y5.62%
Revenue growth 5Y14.46%
Sales Q2Q%-11.15%
Revenue Next Year-1.25%
Revenue Next 2Y2.2%
Revenue Next 3Y1.95%
Revenue Next 5YN/A
EBIT growth 1Y-19.16%
EBIT growth 3Y-15.1%
EBIT growth 5Y16.21%
EBIT Next Year27.48%
EBIT Next 3Y19.04%
EBIT Next 5YN/A
FCF growth 1Y-11.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5.87%
OCF growth 3YN/A
OCF growth 5YN/A